Index RUT P/E - EPS (ttm) -0.70 Insider Own 11.30% Shs Outstand 114.36M Perf Week 2.14%
Market Cap 1.60B Forward P/E - EPS next Y -0.96 Insider Trans -0.42% Shs Float 110.42M Perf Month -4.46%
Enterprise Value 1.24B PEG - EPS next Q -0.29 Inst Own 98.49% Short Float 12.44% Perf Quarter 21.78%
Income -84.60M P/S 2.48 EPS this Y 59.48% Inst Trans 6.17% Short Ratio 4.17 Perf Half Y 22.36%
Sales 644.47M P/B 2.07 EPS next Y -56.15% ROA -8.86% Short Interest 13.74M Perf YTD -10.45%
Book/sh 6.21 P/C 3.58 EPS next 5Y 24.14% ROE -11.30% 52W High 24.38 -47.25% Perf Year -42.51%
Cash/sh 3.59 P/FCF 28.15 EPS past 3/5Y -42.17% -36.10% ROIC -9.95% 52W Low 6.78 89.68% Perf 3Y -65.11%
Dividend Est. - EV/EBITDA - Sales past 3/5Y 7.59% 19.96% Gross Margin 71.72% Volatility 4.86% 4.55% Perf 5Y -88.67%
Dividend TTM - EV/Sales 1.92 EPS Y/Y TTM 65.33% Oper. Margin -23.29% ATR (14) 0.69 Perf 10Y -
Dividend Ex-Date - Quick Ratio 5.23 Sales Y/Y TTM 2.02% Profit Margin -13.13% RSI (14) 45.60 Recom 2.25
Dividend Gr. 3/5Y - - Current Ratio 5.84 EPS Q/Q 187.90% SMA20 -4.91% Beta 2.08 Target Price 14.87
Payout - Debt/Eq 0.11 Sales Q/Q 12.93% SMA50 -2.81% Rel Volume 0.69 Prev Close 13.13
Employees 1306 LT Debt/Eq 0.10 Earnings Aug 07 AMC SMA200 7.53% Avg Volume 3.30M Price 12.86
IPO Sep 12, 2019 Option/Short Yes / Yes EPS/Sales Surpr. 175.72% 24.00% Trades
Volume 2,265,189 Change -2.06%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-11-25 Initiated Piper Sandler
Neutral
$15
Feb-13-25 Downgrade Leerink Partners
Outperform → Market Perform
$25 → $12
Sep-03-24 Initiated Leerink Partners
Outperform
$35
Jul-22-24 Upgrade Jefferies
Hold → Buy
$24
Jul-18-24 Downgrade JP Morgan
Overweight → Neutral
$40 → $20
Jul-10-24 Downgrade Deutsche Bank
Buy → Hold
$55 → $25
Jun-27-24 Downgrade Wolfe Research
Outperform → Peer Perform
Jun-25-24 Downgrade Guggenheim
Buy → Neutral
Jun-03-24 Resumed Jefferies
Hold
$24
May-01-24 Downgrade TD Cowen
Buy → Hold
$57 → $32
Dec-14-23 Initiated Guggenheim
Buy
$60
Dec-13-23 Initiated Wolfe Research
Outperform
$55
Dec-12-23 Upgrade BofA Securities
Underperform → Neutral
$36 → $54
Jul-05-23 Resumed JP Morgan
Overweight
$65
May-10-23 Initiated Barclays
Overweight
$65
Mar-31-23 Initiated Stephens
Overweight
$65
Feb-02-23 Initiated UBS
Neutral
$50
Dec-14-22 Initiated Deutsche Bank
Buy
$50
Aug-18-22 Downgrade Goldman
Neutral → Sell
$55 → $35
Jul-25-22 Initiated Canaccord Genuity
Buy
$55
Show Previous Ratings
Sep-16-25 12:33AM
Sep-12-25 02:25PM
Sep-11-25 11:56AM
Sep-09-25 08:44AM
Aug-27-25 04:05PM
11:34PM
Loading…
Aug-24-25 11:34PM
Aug-22-25 12:04AM
Aug-20-25 12:37AM
Aug-19-25 09:00AM
Aug-14-25 01:35AM
12:45AM
Aug-12-25 10:03AM
Aug-11-25 09:37AM
07:41AM
Aug-08-25 12:21PM
04:45AM
Loading…
04:45AM
Aug-07-25 06:30PM
05:35PM
04:33PM
(Associated Press Finance)
04:05PM
04:04PM
Aug-06-25 12:00PM
Aug-05-25 11:09PM
Aug-01-25 03:00PM
Jul-29-25 12:02AM
Jul-24-25 12:52PM
(Investor's Business Daily)
Jul-17-25 09:00AM
Jul-15-25 09:20AM
Jul-10-25 04:05PM
Jun-23-25 11:34PM
01:39AM
Loading…
01:39AM
Jun-10-25 06:23AM
May-29-25 09:55AM
May-23-25 07:41AM
May-22-25 02:00AM
May-21-25 12:00PM
May-14-25 04:05PM
01:32PM
May-13-25 09:55AM
May-09-25 03:42AM
May-08-25 07:00PM
05:50PM
04:53PM
(Associated Press Finance)
04:05PM
May-07-25 05:20PM
May-01-25 10:01AM
Apr-30-25 04:05PM
Apr-28-25 03:00PM
09:09AM
Apr-14-25 04:05PM
Apr-09-25 05:04AM
Mar-20-25 03:12AM
Mar-18-25 07:00AM
Mar-11-25 05:03AM
Mar-03-25 04:05PM
(PR Newswire) -7.86%
+6.80%
08:03AM
Feb-23-25 11:30AM
Feb-18-25 04:05PM
Feb-13-25 03:10PM
01:57PM
01:53PM
09:42AM
07:36AM
(Thomson Reuters StreetEvents)
02:16AM
Feb-12-25 06:30PM
05:45PM
04:41PM
(Associated Press Finance)
04:39PM
04:05PM
Feb-11-25 09:15AM
08:06AM
Feb-06-25 08:08PM
08:30AM
Feb-05-25 10:00AM
Jan-28-25 04:05PM
Jan-12-25 12:00PM
Jan-08-25 07:30PM
(The Wall Street Journal)
Jan-02-25 04:05PM
Dec-30-24 09:28AM
Dec-24-24 07:30AM
Dec-23-24 04:05PM
Nov-20-24 03:29PM
Nov-19-24 07:11PM
Nov-07-24 04:05PM
Oct-31-24 08:00AM
Oct-30-24 07:36AM
(Thomson Reuters StreetEvents)
03:14AM
Oct-29-24 07:00PM
05:20PM
04:15PM
(Associated Press Finance)
04:05PM
Oct-23-24 12:00PM
Oct-22-24 10:01AM
Oct-15-24 04:05PM
Oct-10-24 04:14PM
01:26PM
07:36AM
Oct-09-24 05:57PM
04:05PM
Oct-04-24 05:05PM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Saxonov Serge Chief Executive Officer Aug 22 '25 Sale 13.79 9,348 128,881 945,892 Aug 26 04:15 PM Taich Adam Chief Financial Officer Aug 22 '25 Sale 13.79 22,315 307,657 309,273 Aug 26 04:14 PM Hindson Benjamin J. See Remarks Aug 22 '25 Sale 13.79 7,486 103,209 440,888 Aug 26 04:12 PM Saxonov Serge Officer Aug 22 '25 Proposed Sale 13.41 9,228 123,747 Aug 22 04:26 PM Hindson Benjamin J. Officer Aug 22 '25 Proposed Sale 13.41 7,393 99,140 Aug 22 04:21 PM Taich Adam Officer Aug 22 '25 Proposed Sale 13.41 22,037 295,516 Aug 22 04:17 PM Saxonov Serge Chief Executive Officer May 22 '25 Sale 8.30 9,343 77,540 1,083,625 May 27 05:08 PM Hindson Benjamin J. See Remarks May 22 '25 Sale 8.30 7,485 62,120 448,374 May 27 05:07 PM Taich Adam Chief Financial Officer May 22 '25 Sale 8.30 4,044 33,562 331,588 May 27 05:06 PM Hindson Benjamin J. Officer May 22 '25 Proposed Sale 9.08 7,392 67,119 May 22 04:44 PM Taich Adam Officer May 22 '25 Proposed Sale 9.08 3,994 36,266 May 22 04:36 PM Saxonov Serge Officer May 22 '25 Proposed Sale 9.08 9,227 83,781 May 22 04:24 PM Saxonov Serge Chief Executive Officer Mar 04 '25 Option Exercise 1.20 50,000 60,000 921,540 Mar 04 06:50 PM Saxonov Serge Chief Executive Officer Feb 28 '25 Sale 10.63 7,942 84,393 871,540 Mar 04 06:50 PM Serge Saxonov Director, CEO Feb 28 '25 Proposed Sale 10.57 7,942 83,947 Feb 28 05:03 PM Hindson Benjamin J. See Remarks Feb 24 '25 Sale 11.07 4,573 50,603 335,324 Feb 26 05:43 PM Saxonov Serge Chief Executive Officer Feb 24 '25 Sale 11.07 5,092 56,346 879,482 Feb 26 05:42 PM MATEO ALAN Director Feb 21 '25 Buy 11.14 40,000 445,572 61,691 Feb 25 05:22 PM Saxonov Serge Officer Feb 24 '25 Proposed Sale 11.56 5,104 59,002 Feb 24 08:01 PM Hindson Benjamin J. Officer Feb 24 '25 Proposed Sale 11.56 4,563 52,748 Feb 24 07:35 PM Saxonov Serge Chief Executive Officer Dec 23 '24 Option Exercise 1.20 12,000 14,400 884,574 Dec 23 08:29 PM Saxonov Serge Chief Executive Officer Nov 22 '24 Sale 13.69 6,693 91,612 872,574 Nov 25 04:53 PM Hindson Benjamin J. See Remarks Nov 22 '24 Sale 13.69 5,807 79,485 339,897 Nov 25 04:52 PM Hindson Benjamin J. Officer Nov 22 '24 Proposed Sale 13.32 5,734 76,377 Nov 22 04:56 PM Saxonov Serge Officer Nov 22 '24 Proposed Sale 13.32 6,608 88,019 Nov 22 04:38 PM
